ReviewFrontiers in radiology2026
Pediatric contrast-enhanced ultrasound in clinical practice: evidence maturity and workflow integration.
Review in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced ultrasound (CEUS) has become an important adjunct in pediatric imaging because it enables real-time assessment of microvascular perfusion without ionizing radiation and without nephrotoxic contrast media. This narrative review synthesizes current evidence and practical applications of pediatric CEUS, with emphasis on intravenous blood-pool CEUS, contrast-enhanced voiding urosonography (ceVUS), and selected luminal or hydrosonographic gastrointestinal applications. Literature was identified through targeted searches of PubMed/MEDLINE and Google Scholar, with priority given to pediatric-specific reviews, systematic reviews, consensus or implementation papers, and key original studies, supplemented by recent publications through March 2026. Current evidence is strongest for ceVUS, focal liver lesion characterization, and targeted CEUS for hemodynamically stable blunt abdominal trauma; in contrast, many non-hepatic abdominal, bowel, interventional, emergency, and critical-care applications remain center-dependent or exploratory and require more standardized pediatric validation. Among pediatric applications, ceVUS remains the most mature and reproducible, offering high diagnostic performance without radiation while also allowing detection of intrarenal reflux. However, evidence maturity differs substantially across indications, and regulatory heterogeneity, operator dependence, reimbursement barriers, differences in technology availability, professional training requirements, limited cost-effectiveness data, and the need for standardized protocols remain important implementation challenges. This review proposes an indication-specific evidence-maturity framework that distinguishes mature applications suitable for broader adoption from center-dependent applications requiring local expertise and local protocolization, and from emerging applications requiring stronger prospective validation. The framework is intended as a pragmatic, non-validated clinical organizing tool rather than as a formal evidence-grading system. Overall, CEUS is well positioned to expand within child-centered imaging pathways that seek to maximize diagnostic yield while minimizing radiation exposure, sedation, and procedural burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.